Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions
Journal of Affective Disorders Mar 09, 2018
Riva-Posse P, et al. - Given that ketamine infusions for depression cause small and transient increases in blood pressure, researchers here examined the cardiovascular safety of ketamine when administered at subanesthetic doses to treat depression. Findings revealed small blood pressure changes when ketamine was administered over 40 minutes at 0.5 mg/kg for the treatment of depression. The changes were, however, well tolerated and clinically insignificant.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries